HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

OPRX

OptimizeRx Corporation (NASDAQ)

Healthcare — Health Information Services

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Strong Buy 1.2 / 5 5 analysts
$6.53
$-0.13 (-1.95%)
Target: $12.40 (89.9%)
Sign in to add OPRX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$114.09M
P/E Ratio (TTM)16.89
Forward P/E5.57
EPS (TTM)$0.36
Dividend Yield-
Profit Margin6.37%
Revenue Growth-9.50%
ROE5.56%
Debt/Equity18.30
Recommendation Strong Buy 1.2
Analyst Target$12.40
Analysts5
Indexes NASDAQ

Technical Indicators

RSI (14)68.8
Beta1.10
SMA 20-
SMA 40-
52-Week High$22.25
52-Week Low$4.54
50-Day Avg$5.55
200-Day Avg$11.00
Avg Volume445.7K
Volume132.8K

Performance Analysis

BULLISH

OPRX shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 11% of its 52-week range.
+ RSI at 68.8 shows positive momentum.
- Revenue declined 9.5% year-over-year.
+ Wall Street consensus is "Strong Buy" from 5 analysts.
+ Average analyst target of $12.40 implies 89.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:24 UTC

Back to Screener Export Report